| Literature DB >> 35747632 |
Mark A Plantz1, Scott A Wu1, Erik B Gerlach1, Nicholas C Arpey1, Peter R Swiatek1, John J Carney1, Vehniah K Tjong1.
Abstract
Purpose: The purpose of this study is to use a large national database to assess short-term adverse events following arthroscopic rotator cuff repair in patients 65 years and older.Entities:
Year: 2022 PMID: 35747632 PMCID: PMC9210468 DOI: 10.1016/j.asmr.2022.04.011
Source DB: PubMed Journal: Arthrosc Sports Med Rehabil ISSN: 2666-061X
Demographics, Patient Variables, and Comorbidity Burden of the Cohort Prior to Matching
| 40-65 Years Old [ | 65+ Years Old [ | ||||
|---|---|---|---|---|---|
| Sex | |||||
| Male | 7,342 | 59.2% | 2,989 | 54.6% | |
| Female | 5,062 | 40.8% | 2.487 | 45.4% | |
| BMI (kg/m2) | |||||
| Underweight | 112 | 0.9% | 55 | 1.0% | .516 |
| Normal | 1,771 | 14.3% | 943 | 17.2% | |
| Overweight | 4,188 | 33.8% | 2,153 | 39.3% | |
| Obese Class I | 3,415 | 27.5% | 1,433 | 26.2% | .059 |
| Obese Class II | 1,743 | 14.1% | 592 | 10.8% | |
| Obese Class III | 1,175 | 9.5% | 300 | 5.5% | |
| Comorbidities | |||||
| Diabetes | 1,969 | 15.9% | 1,136 | 20.7% | |
| Smoking | 2,230 | 18.0% | 405 | 7.4% | |
| COPD | 318 | 2.6% | 241 | 4.4% | |
| Ascites | 0 | 0.0% | 1 | 0.02% | .132 |
| Congestive heart failure | 11 | 0.09% | 14 | 0.3% | |
| Hypertension | 5,061 | 40.8% | 3,419 | 62.4% | |
| Renal failure | 0 | 0.0% | 2 | 0.04% | .094 |
| Dialysis | 14 | 0.1% | 10 | 0.2% | .240 |
| Chronic steroid use | 241 | 1.9% | 135 | 2.5% | |
| Bleeding disorder | 128 | 1.0% | 124 | 2.3% | |
| Transfusion within 48 hours | 1 | 0.01% | 1 | 0.02% | .519 |
| ASA Class | |||||
| Class 1 (No disturbance) | 1,254 | 10.1% | 160 | 2.9% | |
| Class 2 (Mild disturbance) | 7,526 | 60.7% | 2,745 | 50.1% | |
| Class 3 (Severe disturbance) | 3,530 | 28.5% | 2,479 | 45.3% | |
| Class 4+ (Life threatening) | 91 | 0.7% | 88 | 1.6% | |
| Operative time | |||||
| Under 60 minutes | 3,274 | 1,618 | <.001 | ||
| Between 60 and 89 minutes | 4,061 | 1,905 | .004 | ||
| 90+ minute | 5,069 | 1,953 | <.001 | ||
ASA, American Society of Anesthesiologists; BMI, body mass index; COPD, chronic obstructive pulmonary disease.
Short-Term Outcome Complication Measures and Complication Rates Prior to Matching
| 40-65 Years Old [ | 65+ Years Old [ | ||||
|---|---|---|---|---|---|
| Readmission | 115 | 0.9% | 84 | 1.5% | |
| Reoperation | 35 | 0.3% | 12 | 0.2% | .448 |
| Non-home discharge | 76 | 0.6% | 51 | 0.9% | |
| Mortality | 4 | 0.03% | 1 | 0.02% | .606 |
| Surgical complications | |||||
| Overall | 14 | 0.1% | 4 | 0.07% | .610 |
| Superficial surgical site infection | 8 | 0.06% | 2 | 0.04% | .733 |
| Deep surgical site infection | 4 | 0.03% | 1 | 0.02% | >.999 |
| Dehiscence | 2 | 0.02% | 0 | 0.0% | >.999 |
| Bleeding | 1 | 0.01% | 2 | 0.04% | .224 |
| Medical complications | |||||
| Overall | 79 | 0.6% | 70 | 1.3% | |
| Wound infection | 5 | 0.04% | 2 | 0.04% | >.999 |
| Pneumonia | 12 | 0.1% | 16 | 0.3% | |
| Reintubation | 4 | 0.03% | 4 | 0.07% | .259 |
| Failure to wean intubation | 3 | 0.02% | 3 | 0.05% | .379 |
| Pulmonary embolism | 29 | 0.2% | 11 | 0.2% | .760 |
| Renal insufficiency | 2 | 0.02% | 2 | 0.04% | .591 |
| Renal failure | 1 | 0.01% | 2 | 0.04% | .224 |
| Urinary tract infection | 15 | 0.1% | 19 | 0.3% | |
| Cerebrovascular accident | 2 | 0.02% | 2 | 0.04% | .591 |
| Cardiac arrest | 3 | 0.02% | 1 | 0.02% | >.999 |
| Myocardial infarction | 7 | 0.06% | 12 | 0.2% | |
| Deep venous thromboembolism | 15 | 0.1% | 8 | 0.1% | .665 |
| Systemic sepsis | 4 | 0.03% | 4 | 0.07% | .259 |
| Septic shock | 1 | 0.01% | 2 | 0.04% | .224 |
Demographics, Patient Variables, and Comorbidity Burden of the Cohort After Matching
| 40-65 Years Old [ | 65+ Years Old [ | ||||
|---|---|---|---|---|---|
| Sex | |||||
| Male | 2,575 | (55.9%) | 2,575 | (55.9%) | >.999 |
| Female | 2030 | (44.1%) | 2030 | (44.1%) | >.999 |
| BMI (kg/m2) | |||||
| Underweight | 26 | (0.6%) | 26 | (0.6%) | >.999 |
| Normal | 750 | (16.3%) | 750 | (16.3%) | >.999 |
| Overweight | 1,779 | (38.6%) | 1,779 | (38.6%) | >.999 |
| Obese Class I | 1,236 | (26.8%) | 1,236 | (26.8%) | >.999 |
| Obese Class II | 541 | (11.7%) | 541 | (11.7%) | >.999 |
| Obese Class III | 274 | (6.0%) | 274 | (6.0%) | >.999 |
| Comorbidities | |||||
| Diabetes | 871 | (18.9%) | 871 | (18.9%) | >.999 |
| Smoking | 352 | (7.6%) | 352 | (7.6%) | >.999 |
| COPD | 92 | (2.0%) | 92 | (2.0%) | >.999 |
| Ascites | 0 | (0.0%) | 0 | (0.0%) | >.999 |
| Congestive heart failure | 0 | (0.0%) | 0 | (0.0%) | >.999 |
| Hypertension | 2,685 | (58.3%) | 2,685 | (58.3%) | >.999 |
| Renal failure | 0 | (0.0%) | 0 | (0.0%) | >.999 |
| Dialysis | 0 | (0.0%) | 0 | (0.0%) | >.999 |
| Chronic steroid use | 62 | (1.3%) | 62 | (1.3%) | >.999 |
| Bleeding disorder | 31 | (0.7%) | 31 | (0.7%) | >.999 |
| Transfusion within 48 hours | 0 | (0.0%) | 0 | (0.0%) | >.999 |
| ASA Class | |||||
| Class 1 (No disturbance) | 156 | (3.4%) | 156 | (3.4%) | >.999 |
| Class 2 (Mild disturbance) | 2,607 | (56.6%) | 2,607 | (56.6%) | >.999 |
| Class 3 (Severe disturbance) | 1,827 | (39.7%) | 1,827 | (39.7%) | >.999 |
| Class 4+ (Life threatening) | 15 | (0.3%) | 15 | (0.3%) | >.999 |
| Operative time | |||||
| Under 60 minutes | 1,312 | (28.5%) | 1,312 | (28.5%) | >.999 |
| Between 60-89 minutes | 1,585 | (34.4%) | 1,585 | (34.4%) | >.999 |
| 90+ minutes | 1,708 | (37.1%) | 1,708 | (37.1%) | >.999 |
ASA, American Society of Anesthesiologists; BMI, body mass index; COPD, chronic obstructive pulmonary disease.
Short-Term Outcome Complication Measures and Complication Rates After Matching
| 40-65 Years Old [ | 65+ Years Old [ | ||||
|---|---|---|---|---|---|
| Readmission | 44 | (1.0%) | 66 | (1.4%) | |
| Reoperation | 16 | (0.3%) | 12 | (0.3%) | .449 |
| Non-home discharge | 27 | (0.6%) | 36 | (0.8%) | .255 |
| Mortality | 3 | (0.1%) | 0 | (0.0%) | .250 |
| Surgical Complications | |||||
| Overall | 8 | (0.2%) | 3 | (0.1%) | .146 |
| Superficial surgical site infection | 5 | (0.1%) | 1 | (0.0%) | .219 |
| Deep surgical site infection | 1 | (<0.1%) | 1 | (0.0%) | >.999 |
| Dehiscence | 1 | (<0.1%) | 0 | (0.0%) | >.999 |
| Bleeding | 1 | (<0.1%) | 1 | (0.0%) | >.999 |
| Medical Complications | |||||
| Overall | 32 | (0.7%) | 51 | (1.1%) | |
| Wound infection | 3 | (0.1%) | 2 | (0.0%) | .655 |
| Pneumonia | 5 | (0.1%) | 12 | (0.3%) | .089 |
| Reintubation | 0 | (0.0%) | 4 | (0.1%) | .125 |
| Failure to wean intubation | 0 | (0.0%) | 3 | (0.1%) | .250 |
| Pulmonary embolism | 10 | (0.2%) | 5 | (0.1%) | .196 |
| Renal insufficiency | 0 | (0.0%) | 1 | (0.0%) | >.999 |
| Renal failure | 1 | (0.0%) | 2 | (0.0%) | >.999 |
| Urinary tract infection | 9 | (0.2%) | 15 | (0.3%) | .220 |
| Cerebrovascular accident | 1 | (0.0%) | 1 | (0.0%) | >.999 |
| Cardiac arrest | 2 | (0.0%) | 1 | (0.0%) | .564 |
| Myocardial infarction | 4 | (0.1%) | 9 | (0.2%) | .165 |
| Deep venous thromboembolism | 3 | (0.1%) | 7 | (0.2%) | .206 |
| Systemic sepsis | 1 | (0.0%) | 3 | (0.1%) | .317 |
| Septic shock | 0 | (0.0%) | 2 | (0.0%) | .157 |
Risk Factors Associated With Various 30-Day Complication Measures After Matching
| Complication Measure | Likelihood Ratio [95% CI] |
|---|---|
| Readmission | |
| Age (per 5-year unit increase) | 1.154 [1.036–1.285] |
| Hypertension | 2.097 [1.314–3.346] |
| ASA 3+ | 1.963 [1.321–2.919] |
| Reoperation | |
| ASA 3+ | 4.012 [1.752–9.185] |
| Non-home discharge | |
| Obesity Class III | 2.806 [1.407–5.597] |
| Mortality | N.S. |
| Surgical complications | N.S. |
| Medical complications | |
| Age (per 5-year unit increase) | 1.026 [1.001–1.053] |
| Male | 0.554 [0.356–0.861] |
| Normal weight | 0.214 [0.076–0.603] |
| ASA 4 | 8.454 [1.907–37.484] |
ASA, American Society of Anesthesiologists; CI, confidence interval; N.S., not significant.